Scientists from Northwestern University to Present New Data on High Efficiency Electroporation of Human Ion Channels
Gaithersburg, MD, February 24, 2016 – MaxCyte® Inc., the leader in driving the next generation of cell-based medicines with scalable, high-performance cell transfection systems, announces that new data on human ion channels generated using its flow electroporation platform will be presented at the 60th Annual Biophysics Meeting by two prominent professors from Northwestern University, Feinberg School of Medicine.
The following are specific details regarding the presentations:
Drug Discovery for Ion Channel XVI
Satellite Meeting of the Biophysical Society 60th Annual Meeting
Speaker: Dr. Alfred George, Jr., Northwestern University Feinberg School of Medicine
Title: Coupling high capacity electroporation with automated patch clamp recording for functional annotation of human ion channel variants
Date: Friday, February 26, 2016
Time: 4:00-4:30 pm
Location: Room 411, Los Angeles Convention Center
MaxCyte User Group at the 60th Annual Biophysical Annual Meeting
Speaker: Dr. Carlos Vanoye, Northwestern University Feinberg School of Medicine
Title:
High efficiency electroporation of human ion channel variants for automated patch clamp
Date: Sunday, February 28, 2016
Time: 2:30-4:00 pm
Location: Room 513, Los Angeles Convention Center
In addition to the two presentations, MaxCyte scientists will be available for questions in booth 811.
About MaxCyte
MaxCyte is the leader in driving the next generation of cell-based medicines. MaxCyte’s cell modification technology, flow electroporation, is used for discovery, development, and manufacture of small molecule, biologic, and cell-based therapeutics. The MaxCyte GT® Flow Transfection System, the MaxCyte STX® Scalable Transfection System, and the MaxCyte VLX® Large Scale Transfection System enable the rapid development and consistent production of transfected cells for a broad array of applications.
For more information, http://www.maxcyte.com.
